PCM
DGX icon

Permanent Capital Management’s Quest Diagnostics DGX Stock Holding History

Permanent Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
10,706
+6,760
+171% +$1.33M 0.3% 26
2026
Q1 		$766K Buy
+3,946
New +$767K 0.12% 61

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Permanent Capital Management's DGX Position: Q2 2026 in Review

Permanent Capital Management increased its Quest Diagnostics (DGX) stake by 171% in Q2 2026, buying an estimated $1.33M and bringing the position to 10,706 shares worth $2.27M. The position accounts for 0.3% of the portfolio, ranked #26.

Permanent Capital Management first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Permanent Capital Management held 10,706 shares of Quest Diagnostics worth $2.27M as of Q2 2026.
  • Permanent Capital Management bought 6,760 Quest Diagnostics shares in Q2 2026, an estimated $1.33M.
  • Quest Diagnostics made up 0.3% of Permanent Capital Management's portfolio in Q2 2026, its #26 holding.
  • Permanent Capital Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Permanent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.